Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (9377)	6/8/1998 6:10:00 PM
From: Mkilloran	Respond to of 23519

Vlad......UK was approved in Dec for Muse sales....it took the better part of Jan and Feb to rampup.... The last 4 1/2 weeks of the 1st qtr sales were reported at $1.7 mill by Vivus....at ~$7.00 per unit..... I don't have any hard numbers on the UK current scripts...but would think without Viagra competition and review of the rampup in 1997 in the USA .....I'am expecting about 5,000 scripts per week in the UK in the 2nd qtr 1998. Additional countries may take about the same time to rampup...so I'am not expecting anything meaningful in the 2nd qtr....but the 3rd qtr should be a different story....